HIV prevention drug hailed as breakthrough, but who gets access?
Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be available to all.
Covered by 1 source ·
Every side
-
Al Jazeera
Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be available to all.